This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Conference on Cell & Stem Cell Research" (Stem Cells 2023) August 21-23, 2023 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at firstname.lastname@example.org or call + 1 (702) 988 2320.
The world was astonished when a new coronavirus respiratory disease (COVID-19) caused by the SARS-CoV-2 virus emerged, causing social, economic, and health concerns. Since its discovery, various biomedical professionals from around the world have been mobilizing to find a therapy to contain this pandemic infection. As a result, the latest COVID-19 outbreak emphasizes the critical need for safe and effective treatments, particularly for the most severe patients. For regenerative medicine and cellular therapy, stem cells have always been a hot topic. The importance of stem cells in modern medicine is undeniable, both for their application in basic research and for the potential to produce novel medicines in clinical practice. Because of the need of developing innovative and effective treatments for COVID-19, stem cells have taken a prominent role in the scene. Stem cells produced from the amnion of the human placenta, in particular, should be investigated for the treatment of this type of pulmonary diseases, as well as a wide spectrum of disorders, due to their immunoregulatory, reparative, and regenerative qualities.